FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

18 results

azathioprine
(Azathioprine)
Ascend Laboratories, LLC
Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. Its combined use with other disease-modifying anti-rheumatic drugs has not been studied and is not recommended.
azathioprine
(Azathioprine)
Glenmark Pharmaceuticals, Inc
Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal transplants and for managing active rheumatoid arthritis to reduce signs and symptoms. Its use with disease-modifying anti-rheumatic drugs has not been studied, and concurrent use is not recommended.
cellcept
(Mycophenolate Mofetil)
Genentech, Inc.
Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressive agents.
cyclosporine
(CYCLOSPORINE)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Cyclosporine capsules (modified) are indicated for preventing organ rejection in kidney, liver, and heart transplants. They also treat severe rheumatoid arthritis inadequately responding to methotrexate and manage severe, recalcitrant plaque psoriasis in nonimmunocompromised adults who have not responded to other systemic therapies.
cyclosporine
(Cyclosporine)
Strides Pharma Science Limited
Usage: Cyclosporine capsules (modified) are indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who have not adequately responded to systemic therapies or cannot tolerate them.
cyclosporine
(Cyclosporine)
Teva Pharmaceuticals USA, Inc.
Usage: Cyclosporine capsules, USP MODIFIED are indicated for organ rejection prophylaxis in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who failed previous systemic therapies or cannot tolerate them.
gengraf
(Cyclosporine)
AbbVie Inc.
Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.
mycophenolate mofetil
(MYCOPHENOLATE MOFETIL)
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Mycophenolate mofetil (MMF) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used in combination with other immunosuppressants.
mycophenolate mofetil
(Mycophenolate Mofetil hydrochloride)
BPI Labs LLC
Usage: Mycophenolate Mofetil is indicated for preventing organ rejection in adult and pediatric patients (3 months and older) who have received allogeneic kidney, heart, or liver transplants, and is used in combination with other immunosuppressants.
mycophenolate mofetil
(Mycophenolate Mofetil)
Camber Pharmaceuticals, Inc.
Usage: Mycophenolate mofetil capsules are indicated for preventing organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressive agents.

Medications for Kidney Transplantation

azathioprine

azathioprine

cellcept

cyclosporine

cyclosporine

cyclosporine

gengraf

mycophenolate mofetil

mycophenolate mofetil

mycophenolate mofetil